Clinical relevance in chronic myeloid leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL
2012-01-01 Peluso, A. L.; Seneca, E.; Cosenza, M. R.; Quintarelli, C.; Musella, F.; Esposito, N.; Muccioli Casadei, G.; Izzo, B.; Villa, M. R.; Esposito, M. R.; Danise, P.; Pezzullo, L.; Menna, G.; Mettivier, V.; Sessa, U.; Pizzuti, M.; Annunziata, M.; Spieza, M.; Russo, F.; Serio, B.; Palmieri, F.; Vallone, R.; Martino, B.; Iovine, M.; Camera, A.; Luciano, L. and Pane F.
Highly Sensitive Detection of BCR-ABL Kinase Domain Mutations in CML patients by an Ultra-Deep Sequencing Approach
2008-01-01 Dargenio, V; Naso, B; Peluso, A. L.; PANE F., AND SALVATORE F
Decrease level of SHP1 provides an additive survival advantage to Philadelphia chromosome-positive (Ph+) cells derived from patients with chronic myeloid leukemia (CML) and account for resistance to Imatinib (Ima) treatment
2010-01-01 Esposito, N.; Colavita, I.; Quintarelli, C.; Sica, A. R.; Luciano, L.; Del Vecchio, L.; Buonomo, T.; Hughes, T.; Radich, J. P.; Peluso, A. L.; Saglio, G.; Melo, J.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; Pane, F.
Evalution of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies
2004-01-01 Franzese, T; Peluso, A. L.; Mauriello, G; CASABURI A., AND MOSCHETTI G
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies, including chronic myelogenous leukemia
2009-01-01 Quintarelli, C; DE ANGELIS, B; Savoldo, B; Dotti, G; Luciano, L; Izzo, B; Musella, F; Peluso, A. L.; Esposito, N; MUCCIOLI CASADEI, G; Giordano, F; Rinaldi, P; Farina, V; Rinaldi, C; Heslop, H; Rooney, C; Brenner, M; Rotoli, B; Pane, F
Frequencies of cKIT mutations detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangements
2011-01-01 Peluso, A. L.; Izzo, B.; Musella, F.; Rinaldi, P.; Esposito, N.; De Angelis, B.; Errichiello, S.; Muccioli Casadei, G.; Quintarelli, C.; Pane, F.
Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies. Including chronic myelogenous leukemia
2009-01-01 Quintarelli, C.; De Angelis, B.; Savoldo, B.; Dotti, G.; Luciano, L.; Izzo, B.; Musella, F.; Peluso, A. L.; Esposito, N.; Muccioli Casadei, G.; Giordano, F.; Rinaldi, P.; Farina, V.; Rinaldi, C.; Heslop, H.; Rooney, C.; Brenner, M.; Rotoli, B.; Pane, F.
Ligh chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis
2009-01-01 Zeppa, P; Cozzolino, I; Peluso, A. L.; Troncone, G; Malapelle, U; Russo, M; Varone, V; Vetrani, A; Palombini, L
Unravelling the Mechanism of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a Proteomic Approach
2007-01-01 Colavita, I; Esposito, N; Izzo, B; Peluso, A. L.; Martinelli, R; Pane, F; RUOPPOLO M., AND SALVATORE F
Reduced levels of SHP1 provides an additive serviva advantage to the PH- cells of CML patients and may account for resistance to IMA treatment
2008-01-01 Esposito, N; Colavita, I; Izzo, B; Quarantelli, F; Sica, Ra; Buonomo, T; Roberti, V; Luciano, L; DEL VECCHIO, L; Peluso, A. L.; Melo, Jv; Russo, D; Martinelli, G; Martinelli, R; RUOPPOLO M., AND PANE F
La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC)
2010-01-01 Esposito, N.; Colavita, I.; Quintarelli, C.; Sica, A. R.; Luciano, L.; Del Vecchio, L.; Buonomo, T.; Hughes, T. P.; Peluso, A. L.; Saglio, G.; Melo, J. V.; Martinelli, R.; Ruoppolo, M.; Martinelli, G.; Pane, F.
Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients
2009-01-01 Esposito, N.; Quintarelli, C.; Colavita, I.; Izzo, B.; Peluso, A. L.; Ruoppolo, M.; Del Vecchio, L.; Russo, D.; Branford, S.; Iacobucci, I.; Thornquist, M.; Barnett, M.; Melo, J.; Saglio, G.; Radich, J.; Perter, L.; Martinelli, G.; Kalebic, T.; Hughes, T. P.; Pane, F.
The dynamics of ABL mutations onset in PH+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate
2008-01-01 Peluso, A. L.; Grammatico, S; Elia, L; Izzo, B; MUCCIOLI-CASADEI, G; Vitale, D; Andreozzi, Mc; Esposito, N; Picardi, M; Martinelli, G; Soverini, S; CIMINO G., AND PANE F
The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial
2008-01-01 Esposito, N.; Quarantelli, F.; Luciano, L.; Izzo, B.; Peluso, A. L.; Picardi, M.; Branford, S.; White, D. L.; Hughes, T. P.; Radich, J.; Soverini, S.; Iacobucci, I.; Saglio, G.; Kalebic, T.; Thornquist, M.; Martinelli, G.; Pane, F.
Increasing BCR-.ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia
2008-01-01 Grammatico, S; Elia, L; Vitale, A; Matarazzo, M; Falciani, V; Rago, A; Cenfra, N; Peluso, A. L.; Grammatico, P; Pane, F; Meloni, G; FOÀ R., AND CIMINO G
SHP1 expression accounts for resistance to Imatinib treatment in Philadelphia chromosome-positive cells derived from patients with Chronic Myeloid Leukemia
2011-01-01 Esposito, N.; Quintarelli, C.; Colavita, I.; Sica, A. R.; Peluso, A. L.; Errichiello, S.; De Angelis, B.; Musella, F.; Izzo, B.; Muccioli Casadei, G.; Rinaldi, P.; Cosenza, M.; Pisano, I.; Cacciapuoti, V.; Luciano, L.; Picardi, M.; Del Vecchio, L.; Buonomo, T.; Hughes, T. P.; Radich, J. P.; Russo, D.; Branford, S.; Saglio, G.; Melo, J. V.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; Pane, F.
First case of S716del mutation in the cKIT gene and V617V mutation in Jak2 gene in a patient affected by essential thrombocytopenia associated to systemic mastocytosis
2010-01-01 Pugliese, N.; Peluso, A. L.; Quintarelli, C.; Gravetti, A.; Grimaldi, F.; De Angelis, B.; Giagnuolo, G.; Madonna, E.; Martinelli, V.; Pane, F.
ERP 4.0 PER UNA CORRETTA GESTIONE DEI RIFIUTI
2020-01-01 La Bella, S; Carlo Amendola, C; Savastano, M; Belcastro, M
DISCLOSURE ON INTELLECTUAL CAPITAL IN THE AGE OF INDUSTRY 4.0: EVIDENCE FROM ITALIAN CAPITAL MARKET
2018-01-01 Angelini, M. S.; Gennaro, A.; La Bella, S
ERP 4.0 per una corretta gestione dei rifiuti
2020-01-01 Amendola, Carlo; Savastano, Marco; Belcastro, Mattia; LA BELLA, Simone
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Clinical relevance in chronic myeloid leukemia of deletion and insertion events in the tyrosine Kinase domain of BCR-ABL | 1-gen-2012 | Peluso, A. L.; Seneca, E.; Cosenza, M. R.; Quintarelli, C.; Musella, F.; Esposito, N.; Muccioli Casadei, G.; Izzo, B.; Villa, M. R.; Esposito, M. R.; Danise, P.; Pezzullo, L.; Menna, G.; Mettivier, V.; Sessa, U.; Pizzuti, M.; Annunziata, M.; Spieza, M.; Russo, F.; Serio, B.; Palmieri, F.; Vallone, R.; Martino, B.; Iovine, M.; Camera, A.; Luciano, L. and Pane F. | |
| Highly Sensitive Detection of BCR-ABL Kinase Domain Mutations in CML patients by an Ultra-Deep Sequencing Approach | 1-gen-2008 | Dargenio, V; Naso, B; Peluso, A. L.; PANE F., AND SALVATORE F | |
| Decrease level of SHP1 provides an additive survival advantage to Philadelphia chromosome-positive (Ph+) cells derived from patients with chronic myeloid leukemia (CML) and account for resistance to Imatinib (Ima) treatment | 1-gen-2010 | Esposito, N.; Colavita, I.; Quintarelli, C.; Sica, A. R.; Luciano, L.; Del Vecchio, L.; Buonomo, T.; Hughes, T.; Radich, J. P.; Peluso, A. L.; Saglio, G.; Melo, J.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; Pane, F. | |
| Evalution of proteolytic, lipolytic and decarboxylase activity of extremely halophilic bacteria occurring in ripening of salt anchovies | 1-gen-2004 | Franzese, T; Peluso, A. L.; Mauriello, G; CASABURI A., AND MOSCHETTI G | |
| Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies, including chronic myelogenous leukemia | 1-gen-2009 | Quintarelli, C; DE ANGELIS, B; Savoldo, B; Dotti, G; Luciano, L; Izzo, B; Musella, F; Peluso, A. L.; Esposito, N; MUCCIOLI CASADEI, G; Giordano, F; Rinaldi, P; Farina, V; Rinaldi, C; Heslop, H; Rooney, C; Brenner, M; Rotoli, B; Pane, F | |
| Frequencies of cKIT mutations detected in patients with Acute Myeloid Leukemia (AML) characterized by Core Binding Factor (CBF) rearrangements | 1-gen-2011 | Peluso, A. L.; Izzo, B.; Musella, F.; Rinaldi, P.; Esposito, N.; De Angelis, B.; Errichiello, S.; Muccioli Casadei, G.; Quintarelli, C.; Pane, F. | |
| Induction of preferentially expressed antigen of melanoma (PRAME)-specific immunity by PRAME-overlapping pentadecapeptides in patients with hematologic malignancies. Including chronic myelogenous leukemia | 1-gen-2009 | Quintarelli, C.; De Angelis, B.; Savoldo, B.; Dotti, G.; Luciano, L.; Izzo, B.; Musella, F.; Peluso, A. L.; Esposito, N.; Muccioli Casadei, G.; Giordano, F.; Rinaldi, P.; Farina, V.; Rinaldi, C.; Heslop, H.; Rooney, C.; Brenner, M.; Rotoli, B.; Pane, F. | |
| Ligh chains expression of lymphoid infiltrate in fine-needle cytology of Hashimoto's Thyroiditis | 1-gen-2009 | Zeppa, P; Cozzolino, I; Peluso, A. L.; Troncone, G; Malapelle, U; Russo, M; Varone, V; Vetrani, A; Palombini, L | |
| Unravelling the Mechanism of Resistance to Imatinib Mesylate in Chronic Myeloid Leukemia: a Proteomic Approach | 1-gen-2007 | Colavita, I; Esposito, N; Izzo, B; Peluso, A. L.; Martinelli, R; Pane, F; RUOPPOLO M., AND SALVATORE F | |
| Reduced levels of SHP1 provides an additive serviva advantage to the PH- cells of CML patients and may account for resistance to IMA treatment | 1-gen-2008 | Esposito, N; Colavita, I; Izzo, B; Quarantelli, F; Sica, Ra; Buonomo, T; Roberti, V; Luciano, L; DEL VECCHIO, L; Peluso, A. L.; Melo, Jv; Russo, D; Martinelli, G; Martinelli, R; RUOPPOLO M., AND PANE F | |
| La proteina SHP-1 è implicata nella resistenza al trattamenti con Imatinib (Ima) in pazienti affetti da leucemia mieloide cronica (LMC) | 1-gen-2010 | Esposito, N.; Colavita, I.; Quintarelli, C.; Sica, A. R.; Luciano, L.; Del Vecchio, L.; Buonomo, T.; Hughes, T. P.; Peluso, A. L.; Saglio, G.; Melo, J. V.; Martinelli, R.; Ruoppolo, M.; Martinelli, G.; Pane, F. | |
| Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph+ Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients | 1-gen-2009 | Esposito, N.; Quintarelli, C.; Colavita, I.; Izzo, B.; Peluso, A. L.; Ruoppolo, M.; Del Vecchio, L.; Russo, D.; Branford, S.; Iacobucci, I.; Thornquist, M.; Barnett, M.; Melo, J.; Saglio, G.; Radich, J.; Perter, L.; Martinelli, G.; Kalebic, T.; Hughes, T. P.; Pane, F. | |
| The dynamics of ABL mutations onset in PH+ Acute Lymphoblastic Leukemia treated with Imatinib Mesylate | 1-gen-2008 | Peluso, A. L.; Grammatico, S; Elia, L; Izzo, B; MUCCIOLI-CASADEI, G; Vitale, D; Andreozzi, Mc; Esposito, N; Picardi, M; Martinelli, G; Soverini, S; CIMINO G., AND PANE F | |
| The Expression of shp-1 and SHP-2: A Novel Powerful Predictor of Major Molecular Response (MMR) Achievement in Chronic Myeloid Leukemia Gleevec-Treated Patients Enrolled into the TOPS Clinical Trial | 1-gen-2008 | Esposito, N.; Quarantelli, F.; Luciano, L.; Izzo, B.; Peluso, A. L.; Picardi, M.; Branford, S.; White, D. L.; Hughes, T. P.; Radich, J.; Soverini, S.; Iacobucci, I.; Saglio, G.; Kalebic, T.; Thornquist, M.; Martinelli, G.; Pane, F. | |
| Increasing BCR-.ABL expression levels and/or occurrence of ABL point mutations not always predict resistance to Imatinib Mesylate in BCR-ABL positive Acute Lymphoblastic Leukemia | 1-gen-2008 | Grammatico, S; Elia, L; Vitale, A; Matarazzo, M; Falciani, V; Rago, A; Cenfra, N; Peluso, A. L.; Grammatico, P; Pane, F; Meloni, G; FOÀ R., AND CIMINO G | |
| SHP1 expression accounts for resistance to Imatinib treatment in Philadelphia chromosome-positive cells derived from patients with Chronic Myeloid Leukemia | 1-gen-2011 | Esposito, N.; Quintarelli, C.; Colavita, I.; Sica, A. R.; Peluso, A. L.; Errichiello, S.; De Angelis, B.; Musella, F.; Izzo, B.; Muccioli Casadei, G.; Rinaldi, P.; Cosenza, M.; Pisano, I.; Cacciapuoti, V.; Luciano, L.; Picardi, M.; Del Vecchio, L.; Buonomo, T.; Hughes, T. P.; Radich, J. P.; Russo, D.; Branford, S.; Saglio, G.; Melo, J. V.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; Pane, F. | |
| First case of S716del mutation in the cKIT gene and V617V mutation in Jak2 gene in a patient affected by essential thrombocytopenia associated to systemic mastocytosis | 1-gen-2010 | Pugliese, N.; Peluso, A. L.; Quintarelli, C.; Gravetti, A.; Grimaldi, F.; De Angelis, B.; Giagnuolo, G.; Madonna, E.; Martinelli, V.; Pane, F. | |
| ERP 4.0 PER UNA CORRETTA GESTIONE DEI RIFIUTI | 1-gen-2020 | La Bella, S; Carlo Amendola, C; Savastano, M; Belcastro, M | |
| DISCLOSURE ON INTELLECTUAL CAPITAL IN THE AGE OF INDUSTRY 4.0: EVIDENCE FROM ITALIAN CAPITAL MARKET | 1-gen-2018 | Angelini, M. S.; Gennaro, A.; La Bella, S | |
| ERP 4.0 per una corretta gestione dei rifiuti | 1-gen-2020 | Amendola, Carlo; Savastano, Marco; Belcastro, Mattia; LA BELLA, Simone |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...1326
Data di pubblicazione
- In corso di stampa7
- 2020 - 2025232
- 2010 - 2019569
- 2000 - 2009476
- 1990 - 199939
- 1987 - 19893
Editore
- ACM16
- Springer9
- GI8
- Giappichelli8
- International Association for Ene...8
- Morlacchi Editore8
- AIDI - Italian Association of Ind...6
- Elsevier B.V.6
- American Society of Mechanical En...5
- Editoriale Scientifica5
Rivista
- IOP CONFERENCE SERIES: MATERIALS ...10
- ENERGY PROCEDIA7
- PROCEDIA STRUCTURAL INTEGRITY7
- ...SUMMER SCHOOL FRANCESCO TURCO....6
- SAE TECHNICAL PAPER5
- IOP CONFERENCE SERIES: MATERIALS ...3
- ATTI DELLA ACCADEMIA LANCISIANA2
- E3S WEB OF CONFERENCES2
- IOP CONFERENCE SERIES. EARTH AND ...2
- JOURNAL OF PHYSICS. A, MATHEMATIC...2
Serie
- CEUR WORKSHOP PROCEEDINGS4
- COMMUNICATIONS IN COMPUTER AND IN...3
- ...IEEE INTERNATIONAL CONFERENCE ...1
- CONSONANZE1
- IFIP ADVANCES IN INFORMATION AND ...1
- PROCEEDINGS - WINTER SIMULATION C...1
- PROCEEDINGS OF THE ANNUAL HAWAII ...1
Keyword
- Axiomatic Design17
- Fashion9
- Aeronautica Italiana6
- aspetto6
- corporate reputation6
- Fault modeling6
- GPU6
- OpenVX6
- Embedded vision5
- Industry 4.05
Lingua
- eng668
- ita258
- und19
- fre3
- ger2
- pol2
- spa2
- rus1
Accesso al fulltext
- no fulltext1045
- reserved281